In August 2022 the India National Anti-Doping Agency (INADA) has reported an anti-doping rule violation against the bodybuilder Suprity Archarjee after her sample tested positive for the prohibited substance Stanozolol. The Athlete admitted the violation and could not demonstrate that the violation was not intentional.
Following notification a provisional suspension was ordered. Thereupon the case was referred to the Anti-Doping Disciplinary Panel of India (ADDPI).
The Panel finds that the presence of the prohibited substance has been established in the Athlete's sample and accordingly that she committed an anti-doping rule violation.
Therefore the ADDPI Panel decides on 3 February 2023 to impose a 4 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 16 August 2022.
